{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:21:53Z","timestamp":1790889713276,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1007\/s11920-004-0065-1","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:12:08Z","timestamp":1180782728000},"page":"202-209","source":"Crossref","is-referenced-by-count":8,"title":["Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?"],"prefix":"10.1007","volume":"6","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranga R.","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"65_CR1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archinte.1989.00390080059014","volume":"149","author":"SJ Schleifer","year":"1989","unstructured":"Schleifer SJ, Macari-Hinson MM, Coyle DA, et al.: The nature and course of depression following myocardial infarction. Arch Intern Med 1989, 149:1785\u20131789.","journal-title":"Arch Intern Med"},{"key":"65_CR2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","volume":"270","author":"N Frasure-Smith","year":"1993","unstructured":"Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction: impact on 6-month survival. JAMA 1993, 270:1819\u20131825.","journal-title":"JAMA"},{"key":"65_CR3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0002-8703(99)70159-6","volume":"138","author":"MW Kaufman","year":"1999","unstructured":"Kaufman MW, Fitzgibbons JP, Sussman EJ, et al.: Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999, 138:549\u2013554.","journal-title":"Am Heart J"},{"key":"65_CR4","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.","edition":"edn 4"},{"key":"65_CR5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","volume":"91","author":"N Frasure-Smith","year":"1995","unstructured":"Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995, 91:999\u20131005.","journal-title":"Circulation"},{"key":"65_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00006842-200103000-00005","volume":"63","author":"D Lane","year":"2001","unstructured":"Lane D, Carroll D, Ring C, et al.: Mortality and quality of life after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001, 63:221\u2013230.","journal-title":"Psychosom Med"},{"key":"65_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(94)90877-X","volume":"343","author":"KH Ladwig","year":"1994","unstructured":"Ladwig KH, Roll G, Breithardt G, et al.: Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994, 343:20\u201323.","journal-title":"Lancet"},{"key":"65_CR8","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(01)06803-9","volume":"358","author":"I Connerney","year":"2001","unstructured":"Connerney I, Shapiro PA, McLaughlin JS, et al.: Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet 2001, 358:1766\u20131771.","journal-title":"Lancet"},{"key":"65_CR9","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archinte.160.9.1354","volume":"160","author":"F Lesperance","year":"2000","unstructured":"Lesperance F, Frasure-Smith N, Juneau M, Theroux P: Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000, 160:1354\u20131360.","journal-title":"Arch Intern Med"},{"key":"65_CR10","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","volume":"161","author":"W Jiang","year":"2001","unstructured":"Jiang W, Alexander J, Christopher E, et al.: Effect of depression on mortality and morbidity in patients with congestive heart failure. Arch Intern Med 2001, 161:1849\u20131856.","journal-title":"Arch Intern Med"},{"key":"65_CR11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006842-198811000-00009","volume":"50","author":"RM Carney","year":"1988","unstructured":"Carney RM, Rich MW, Freedland KE, et al.: Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988, 50:627\u2013633.","journal-title":"Psychosom Med"},{"key":"65_CR12","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9149(96)00380-3","volume":"78","author":"JC Barefoot","year":"1996","unstructured":"Barefoot JC, Helms MJ, Mark DB, et al.: Depression and longterm mortality risk in patients with coronary artery disease. Am J Cardiol 1996, 78:613\u2013617.","journal-title":"Am J Cardiol"},{"key":"65_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199307000-00003","volume":"4","author":"R Anda","year":"1993","unstructured":"Anda R, Williamson D, Jones D, et al.: Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults. Epidemiology 1993, 4:285\u2013294.","journal-title":"Epidemiology"},{"key":"65_CR14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archinte.160.9.1261","volume":"160","author":"AK Ferketich","year":"2000","unstructured":"Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study: National Health and Nutrition Examination Survey. Arch Intern Med 2000, 160:1261\u20131268.","journal-title":"Arch Intern Med"},{"key":"65_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","volume":"58","author":"BW Penninx","year":"2001","unstructured":"Penninx BW, Beekman AT, Honig A, et al.: Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001, 58:221\u2013227.","journal-title":"Arch Gen Psychiatry"},{"key":"65_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00023210-200216020-00004","volume":"16","author":"W Jiang","year":"2002","unstructured":"Jiang W, Krishnan RK, O\u2019Connor CM: Depression and hear disease: evidence of a link, and its therapeutic implications. CNS Drugs 2002, 16:111\u2013127.","journal-title":"CNS Drugs"},{"key":"65_CR17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archpsyc.1990.01810240013002","volume":"47","author":"E Frank","year":"1990","unstructured":"Frank E, Kupfer DJ, Perel JM, et al.: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990, 47:1093\u20131099.","journal-title":"Arch Gen Psychiatry"},{"key":"65_CR18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1056\/NEJM198204223061603","volume":"306","author":"RC Veith","year":"1982","unstructured":"Veith RC, Raskind MA, Caldwell JH, et al.: Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 1982, 306:954\u2013959.","journal-title":"N Engl J Med"},{"key":"65_CR19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.156.7.1024","volume":"156","author":"JC Nelson","year":"1999","unstructured":"Nelson JC, Kennedy JS, Pollock BG, et al.: Treatment of major depression with amitriptyline and paroxetine in patients with ischemic heart disease. Am J Psychiatry 1999, 156:1024\u20131028.","journal-title":"Am J Psychiatry"},{"key":"65_CR20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","volume":"321","author":"CAST Investigators","year":"1989","unstructured":"CAST Investigators: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989, 321:406\u2013421.","journal-title":"N Engl J Med"},{"key":"65_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","volume":"327","author":"CAST II Investigators","year":"1992","unstructured":"CAST II Investigators: Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992, 327:227\u2013233.","journal-title":"N Engl J Med"},{"key":"65_CR22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(79)90824-9","volume":"1","author":"AH Glassman","year":"1979","unstructured":"Glassman AH, Bigger JT,Jr., Giardina EV, et al.: Clinical characteristics of imipramine-induced orthostatic hypotension. Lancet 1979, 1:468\u2013472.","journal-title":"Lancet"},{"key":"65_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00004714-198708000-00007","volume":"7","author":"SP Roose","year":"1987","unstructured":"Roose SP, Glassman AH, Giardina EG, et al.: Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. J Clin Psychopharmacol 1987, 7:247\u2013251.","journal-title":"J Clin Psychopharmacol"},{"key":"65_CR24","first-page":"338","volume":"52","author":"SP Roose","year":"1991","unstructured":"Roose SP, Dalack GW, Glassman AH, et al.: Is doxepin a safer tricyclic for the heart? J Clin Psychiatry 1991, 52:338\u2013341.","journal-title":"J Clin Psychiatry"},{"key":"65_CR25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00006842-200011000-00007","volume":"62","author":"JJMH Strik","year":"2000","unstructured":"Strik JJMH, Honig A, Lousberg R, et al.: Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom Med 2000, 62:783\u2013789.","journal-title":"Psychosom Med"},{"key":"65_CR26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2125.1988.tb03397.x","volume":"26","author":"JW Upward","year":"1988","unstructured":"Upward JW, Edwards JG, Goldie A, et al.: Comparative effects of fluoxetine and amitriptyline on cardiac function. Br J Clin Pharmacol 1988, 26:399\u2013402.","journal-title":"Br J Clin Pharmacol"},{"key":"65_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-199702000-00004","volume":"17","author":"B Baker","year":"1997","unstructured":"Baker B, Dorian P, Sandor P, et al.: Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. J Clin Psychopharmacol 1997, 17:15\u201321.","journal-title":"J Clin Psychopharmacol"},{"key":"65_CR28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","volume":"288","author":"AH Glassman","year":"2002","unstructured":"Glassman AH, O\u2019Connor CM, Califf RM, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701\u2013709. This is the largest sample study that has examined the cardiac safety and antidepressant efficacy of sertraline compared with placebo in patients with postacute coronary syndrome.","journal-title":"JAMA"},{"key":"65_CR29","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","volume":"289","author":"Writing Committee for the ENRICHD Investigators","year":"2003","unstructured":"Writing Committee for the ENRICHD Investigators: Effects of Treating Depression and Low Perceived Social Support on Clinical Events After Myocardial Infarction The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 2003, 289:3106\u20133116. Although post hoc and nonrandomized and non-placebo-controlled, this study demonstrated that SSRI use, compared with no antidepressant use, in a relatively well-monitored setting, reduced cardiac events in post-MI patients.","journal-title":"JAMA"},{"key":"65_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1067\/mhj.2002.123580","volume":"144","author":"RH Brink Van den","year":"2002","unstructured":"Van den Brink RH, Van Melle JP, Honig A, et al.: Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial Infarction and Depression-Intervention Trial (MIND-IT). Am Heart J 2002, 144:219\u2013225.","journal-title":"Am Heart J"},{"key":"65_CR31","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archpsyc.55.7.580","volume":"55","author":"DL Musselman","year":"1998","unstructured":"Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55:580\u2013592.","journal-title":"Arch Gen Psychiatry"},{"key":"65_CR32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM199501193320312","volume":"332","author":"J Lefkowitz","year":"1995","unstructured":"Lefkowitz J, Plow EF, Topol EJ: Platelet glycoprotein IIb\/IIIa receptors in cardiovascular medicine. N Engl J Med 1995, 332:1553\u20131559.","journal-title":"N Engl J Med"},{"key":"65_CR33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00006842-199111000-00006","volume":"53","author":"JH Markowitz","year":"1991","unstructured":"Markowitz JH, Matthews KA: Platelets and coronary heart disease: potential psychophysiologic mechanisms. Psychosom Med 1991, 53:643\u2013668.","journal-title":"Psychosom Med"},{"key":"65_CR34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0735-1097(98)00515-4","volume":"33","author":"DJ Schneider","year":"1999","unstructured":"Schneider DJ, Taatjes DJ, Howard DB, et al.: Increased reactivity of platelets induced by fibrinogen independent of its binding to the IIb\/IIIa surface glycoprotein: a potential contributor to cardiovascular risk. J Am Coll Cardiol 1999, 33:261\u2013266.","journal-title":"J Am Coll Cardiol"},{"key":"65_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.1994.tb02422.x","volume":"24","author":"JG White","year":"1994","unstructured":"White JG: Platelets and atherosclerosis. Eur J Clin Investigation 1994, 24(suppl):25\u201329.","journal-title":"Eur J Clin Investigation"},{"key":"65_CR36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJM199303043280907","volume":"328","author":"JA Ware","year":"1993","unstructured":"Ware JA, Heistad DD: Seminars in medicine of the Beth Israel Hospital: platelet-endothelium interactions. N Engl J Med 1993, 328:628\u2013635.","journal-title":"N Engl J Med"},{"key":"65_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.CIR.54.3.365","volume":"54","author":"JD Folts","year":"1976","unstructured":"Folts JD, Browell EB, Rowe GG: Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation 1976, 54:365.","journal-title":"Circulation"},{"key":"65_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.CIR.65.2.248","volume":"65","author":"JD Folts","year":"1982","unstructured":"Folts JD, Gallagher K, Rowe GG: Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation. Circulation 1982, 65:248.","journal-title":"Circulation"},{"key":"65_CR39","first-page":"I16","volume":"81","author":"P Grande","year":"1990","unstructured":"Grande P, Grauholt AM, Madsen JK: Unstable angina pectoris: platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation 1990, 81(suppl):I16-I19.","journal-title":"Circulation"},{"key":"65_CR40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.CIR.73.3.418","volume":"73","author":"MJ Davies","year":"1986","unstructured":"Davies MJ, Thomas AC, Knapman PA, Hangartner JR: Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986, 73:418\u2013427.","journal-title":"Circulation"},{"key":"65_CR41","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","volume":"322","author":"MD Trip","year":"1990","unstructured":"Trip MD, Cats VM, van Capelle FJ, Vreeken J: Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990, 322:1549\u20131554.","journal-title":"N Engl J Med"},{"key":"65_CR42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","volume":"309","author":"HD Lewis Jr.","year":"1983","unstructured":"Lewis HD, Jr., Davis JW, Archibald DG, et al.: Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina: results of a Veterans Administration Cooperative Study. N Engl J Med 1983, 309:396\u2013403.","journal-title":"N Engl J Med"},{"key":"65_CR43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","volume":"336","author":"The RISC Group","year":"1990","unstructured":"The RISC Group: Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group. Lancet 1990, 336:827\u2013830.","journal-title":"Lancet"},{"key":"65_CR44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.71.6.1129","volume":"71","author":"SP Levine","year":"1985","unstructured":"Levine SP, Towell BL, Suarez AM, et al.: Platelet activation and secretion associated with emotional stress. Circulation 1985, 71:1129\u20131134.","journal-title":"Circulation"},{"key":"65_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-0038-1645048","volume":"63","author":"M Rostrup","year":"1990","unstructured":"Rostrup M, Mundal HH, Kjeldsen SE, et al.: Awareness of hi blood pressure stimulates platelet release reaction. Thromb Haemost 1990, 63:367\u2013370.","journal-title":"Thromb Haemost"},{"key":"65_CR46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1176\/ajp.153.10.1313","volume":"153","author":"DL Musselman","year":"1996","unstructured":"Musselman DL, Tomer A, Manatunga AK, et al.: Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996, 153:1313\u20131317.","journal-title":"Am J Psychiatry"},{"key":"65_CR47","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/00006842-199809000-00013","volume":"60","author":"JH Markovitz","year":"1998","unstructured":"Markovitz JH: Hostility is associated with increased platelet activation in coronary heart disease. Psychosom Med 1998, 60:586\u2013591.","journal-title":"Psychosom Med"},{"key":"65_CR48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-1781(96)02828-4","volume":"62","author":"T Reichborn-Kjennerud","year":"1996","unstructured":"Reichborn-Kjennerud T, Lingjaerde O, Oreland L: Platelet monoamine oxidase activity in patients with winter seasonal affective disorder. Psychiatry Res 1996, 62:273\u2013280.","journal-title":"Psychiatry Res"},{"key":"65_CR49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-1781(01)00259-1","volume":"102","author":"F Lederbogen","year":"2001","unstructured":"Lederbogen F, Gilles M, Maras A, et al.: Increased platelet aggregability in major depression? Psychiatry Res 2001, 102:255\u2013261.","journal-title":"Psychiatry Res"},{"key":"65_CR50","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0006-3223(96)00345-9","volume":"42","author":"F Laghrissi-Thode","year":"1997","unstructured":"Laghrissi-Thode F, Wagner WR, Pollock BG, et al.: Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997, 42:290\u2013295.","journal-title":"Biol Psychiatry"},{"key":"65_CR51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000468450","volume":"15","author":"J Ishigooka","year":"1980","unstructured":"Ishigooka J, Tanaka K, Suzuki Y, et al.: Selective inhibitorory effects of chlorpromazine and imipramine on platelet aggregation. Int Pharmacopsychiatry 1980, 15:270\u2013280.","journal-title":"Int Pharmacopsychiatry"},{"key":"65_CR52","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0009-9236(99)90071-1","volume":"66","author":"JC Alvarez","year":"1999","unstructured":"Alvarez JC, Gluck N, Arnulf I, et al.: Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther 1999, 66:617\u2013624.","journal-title":"Clin Pharmacol Ther"},{"key":"65_CR53","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004714-200004000-00004","volume":"20","author":"BG Pollock","year":"2000","unstructured":"Pollock BG, Laghrissi-Thode F, Wagner WR: Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000, 20:137\u2013140.","journal-title":"J Clin Psychopharmacol"},{"key":"65_CR54","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/appi.ajp.157.6.1006","volume":"157","author":"JH Markovitz","year":"2000","unstructured":"Markovitz JH, Shuster JL, Chitwood WS, et al.: Platelet activation in depression and effects of sertraline treatment: an open-label study. Am J Psychiatry 2000, 157:1006\u20131008.","journal-title":"Am J Psychiatry"},{"key":"65_CR55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archpsyc.57.9.875","volume":"57","author":"DL Musselman","year":"2000","unstructured":"Musselman DL, Marzec UM, Manatunga A, et al.: Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000, 57:875\u2013882.","journal-title":"Arch Gen Psychiatry"},{"key":"65_CR56","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","volume":"108","author":"VL Serebruany","year":"2003","unstructured":"Serebruany VL, Glassman AH, Malinin AI, et al.: Endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation 2003, 108:939\u2013944. This study presented the effects of sertraline on platelet activities compared with placebo in patients postacute coronary syndrome.","journal-title":"Circulation"},{"key":"65_CR57","first-page":"445","volume":"56","author":"P Vandel","year":"2001","unstructured":"Vandel P, Vandel S, Kantelip JP: SSRI-induced bleeding: two case reports. Therapie 2001, 56:445\u2013447.","journal-title":"Therapie"},{"key":"65_CR58","first-page":"727","volume":"114","author":"JE Humphries","year":"1990","unstructured":"Humphries JE, Wheby MS, Vandenberg HJ: Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990, 114:727\u2013728.","journal-title":"Arch Pathol Lab Med"},{"key":"65_CR59","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.319.7217.1106","volume":"319","author":"FJ Abajo De","year":"1999","unstructured":"De Abajo FJ, Rodriguez LAG, Montero D: Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999, 319:1106\u20131109.","journal-title":"BMJ"},{"key":"65_CR60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","volume":"163","author":"SO Dalton","year":"2003","unstructured":"Dalton SO, Johanse C, Mellemkjer L, et al.: Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding. Arch Intern Med 2003, 163:59\u201364.","journal-title":"Arch Intern Med"},{"key":"65_CR61","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/archinte.163.19.2354","volume":"163","author":"K Movig","year":"2003","unstructured":"Movig K, Janssen M, Malefijt J, et al.: Relationship of serotonergic antidepressants and need for bleed transfusion in orthopedic surgical patients. Arch Intern Med 2003, 163:2354\u20132358.","journal-title":"Arch Intern Med"},{"key":"65_CR62","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1176\/appi.ajp.160.10.1823","volume":"160","author":"RE Jorge","year":"2003","unstructured":"Jorge RE, Robinson RG, Arndt S, Starkstein S: Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003, 160:1823\u20131829.","journal-title":"Am J Psychiatry"},{"key":"65_CR63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00004850-198810000-00005","volume":"3","author":"J Butler","year":"1988","unstructured":"Butler J, Leonard BE: The platelet serotonergic system in depression and following sertraline treatment. Int Clin Psychopharmacol 1988, 3:343\u2013347.","journal-title":"Int Clin Psychopharmacol"},{"key":"65_CR64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/phrs.2001.0817","volume":"43","author":"VL Serebruany","year":"2001","unstructured":"Serebruany VL, Gurbel PA, O\u2019Connor CM: Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res 2001, 43:453\u2013462.","journal-title":"Pharmacol Res"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0065-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-004-0065-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0065-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T18:53:30Z","timestamp":1707936810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-004-0065-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1007\/s11920-004-0065-1","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}